(Q40599197)

21 September 2017

Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. (English)

1 reference

21 September 2017

Eun Hee Kim

1

1 reference

21 September 2017

Seung U Kim

series ordinal

2

1 reference

21 September 2017

Deug Y Shin

series ordinal

3

1 reference

21 September 2017

Kyeong Sook Choi

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

446-456

1 reference

21 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207025

21 September 2017

0 references

cites work

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Neuroimmunology of gangliosides in human neurons and glial cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

Target protease specificity of the viral serpin CrmA. Analysis of five caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Validating survivin as a cancer therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

IAP family proteins--suppressors of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Antigen expression by glial cells grown in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Mitochondrial control of cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

A p34(cdc2) survival checkpoint in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Molecular changes during the genesis of human gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Inhibition of fas death signals by FLIPs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207025

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207025

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference